Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described

M. B.R. Lachtermacher, H. N. Seuánez, A. B. Moser, H. W. Moser, K. D. Smith

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


X-linked Adrenoleukodystrophy (X-ALD) is the most frequent peroxisomal disease. It mainly involves the nervous system white matter, adrenal cortex and testes. Several distinct clinical phenotypes are known. The principal biochemical abnormality is the accumulation of saturated very long-chain fatty acids (VLCFAs: > C22:0, mainly C26:0), which is due to impaired capacity for β-oxidation in peroxisomes. Diagnosis is usually based on the VLCFA levels in plasma or cultured skin fibroblasts in both patients and carriers. In 0.1% of affected males, however, the plasma C26:0 level is borderline normal, and 15% of obligate female carders have normal results. Effective mutation detection in these families is therefore fundamental to unambiguously determine the genetic status of each individual at risk. Of particular concern are female members of kindreds segregating X-ALD mutations, because normal VLCFA levels do not guarantee lack of carder status. We describe a fast method for detection of X-ALD mutations. The method is based on SSCP analysis of nested PCR fragments followed by sequence-determination reactions. Using this methodology we have found X-ALD mutations in 30 kindreds, including 15 not previously reported.

Original languageEnglish (US)
Pages (from-to)348-353
Number of pages6
JournalHuman mutation
Issue number4
StatePublished - 2000


  • ABCD1
  • SSCP
  • X-ALDP
  • X-linked adrenoleukodystrophy

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described'. Together they form a unique fingerprint.

Cite this